Commonwealth Equity Services’s Cognition Therapeutics CGTX Stock Holding History

Commonwealth Equity Services’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-41,665	Closed	-$18K	–	4268
2025 Q1	$18K	Sell	41,665 -49,000	-54%	-$28.8K	﹤0.01%	4129
2024 Q4	$64K	Hold	90,665	–	–	﹤0.01%	3963
2024 Q3	$42K	Hold	90,665	–	–	﹤0.01%	3949
2024 Q2	$151K	Sell	90,665 -2,000	-2%	-$3.99K	﹤0.01%	3723
2024 Q1	$169K	Sell	92,665 -65	-0.1%	-$134	﹤0.01%	3682
2023 Q4	$172K	Hold	92,730	–	–	﹤0.01%	3564
2023 Q3	$134K	Sell	92,730 -505	-0.5%	-$791	﹤0.01%	3508
2023 Q2	$171K	Sell	93,235 -75,457	-45%	-$160K	﹤0.01%	3450
2023 Q1	$334	Sell	168,692 -20,615	-11%	-$39.3K	﹤0.01%	2872
2022 Q4	$397K	Sell	189,307 -29,762	-14%	-$60.1K	﹤0.01%	2654
2022 Q3	$416K	Buy	219,069 +4,108	+2%	+$8.56K	﹤0.01%	2565
2022 Q2	$453K	Buy	214,961 +201,071	+1,448%	+$520K	﹤0.01%	2477
2022 Q1	$38K	Buy	+13,890	New	+$53.5K	﹤0.01%	3611

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Commonwealth Equity Services's CGTX Position: Q2 2025 in Review

Commonwealth Equity Services sold out of Cognition Therapeutics (CGTX) in Q2 2025, closing a stake of 41,665 shares — an estimated $18K sold.

Commonwealth Equity Services first reported a position in CGTX in Q1 2022 and held it in 13 quarters. The position peaked at $453K in Q2 2022. 48 funds tracked by Wall St. Rank hold CGTX as of Q2 2025.

Commonwealth Equity Services reported no remaining Cognition Therapeutics position as of Q2 2025 after selling out during the quarter.
Commonwealth Equity Services sold 41,665 Cognition Therapeutics shares in Q2 2025, an estimated $18K.
Commonwealth Equity Services first reported a position in Cognition Therapeutics in Q1 2022 and held it in 13 quarters.
Commonwealth Equity Services's Cognition Therapeutics position peaked at $453K in Q2 2022.
48 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2025.

Based on Commonwealth Equity Services's 13F filing for Q2 2025, filed 6 Aug 2025.